Quantcast

Latest Bioethics Stories

2014-05-01 12:24:48

DENVER, May 1, 2014 /PRNewswire/ -- Cal-Bay International, Inc. (OTC Markets: CBYI) Cal-Bay International, Today Unveiled The Company's Newly Acquired "Snapgrowth" All Natural Plant Enhancement Technology. Cal-Bay recently acquired the proprietary all natural plant enhancement technology for retail and wholesale distribution initially by way of the company's E-commerce storefront(s) launching in May 2014. Distributor's network opportunities will be available later this year. The...

2014-04-30 08:34:12

LEXINGTON, Massachusetts, April 30, 2014 /PRNewswire/ -- - OPUS-2, a Phase 3 placebo-controlled study of lifitegrast 5.0%; results presented at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting in Boston - SONATA, a Phase 3 placebo-controlled, long-term (one-year) safety study of lifitegrast 5.0%; top-line results announced Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty...

2014-04-29 23:18:12

Listen Live on Coast to Coast with George Noory as Dr. Joe introduces the release of his new book You Are the Placebo: Making Your Mind Matter. Also, Join Dr. Joe for a live You Are the Placebo Teleclass with Insight Events at 6pm PST Sign up free here - http://insighteventsusa.com/placebo-teleclass/. (PRWEB) April 29, 2014 In You Are the Placebo: Making Your Mind Matter, Dr. Joe Dispenza explores the history, the science, and the practical applications of the so-called placebo effect....

2014-04-26 16:20:49

Clinical Trials Point Toward 'ATX-101' as Potential Noninvasive Solution for Reduction of Submental Fat SAN FRANCISCO, April 26, 2014 /PRNewswire-USNewswire/ -- Skin laxity and fat buildup under the chin is a common concern among facial aesthetic patients. Although surgery has long been the mainstay for reducing fat in this area, which is also known as the submental region, new research being presented at the Annual Meeting of the American Society for Aesthetic Plastic Surgery (ASAPS) being...

2014-04-24 16:29:59

PHILADELPHIA, April 24, 2014 /PRNewswire-USNewswire/ -- A new study suggests that targeting B cells, which are a type of white blood cell in the immune system, may be associated with reduced disease activity for people with multiple sclerosis (MS). The study is released today and will be presented at the American Academy of Neurology's 66th Annual Meeting in Philadelphia, April 26 to May 3, 2014. For the study, 231 people with relapsing-remitting MS received either a placebo or one...

2014-04-23 23:16:03

As a professor of law and ethics, Rebecca Dresser had been teaching and writing for years about dealing with cancer. Yet she found herself personally unprepared for the experience. San Diego, CA (PRWEB) April 23, 2014 In 2006, when Rebecca Dresser was diagnosed with oral cancer, her life was thrown off-balance. A professor of law and ethics at Washington University in St. Louis, Dresser had been teaching and writing for years about dealing with life-threatening diseases. Yet she found...

2014-04-18 04:20:58

DUBLIN, April 18, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/ddkpws/mice_model_market) has announced the addition of the "Mice Model Market - by Type, Technology, Disease, Service & Care Products - Forecasts to 2018" [http://www.researchandmarkets.com/research/ddkpws/mice_model_market ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Over the years, the use of mice models has...

2014-04-16 16:30:19

TORONTO, April 16, 2014 /CNW/ - Ontario's doctors are helping to mark Advance Care Planning Day today by encouraging everyone to take a moment and consider their end-of-life wishes. Advance care planning starts with thinking about your wishes, values and beliefs about the health care you would want if you were ever incapable of making decisions for yourself, and then talking about them with loved ones. "A medical crisis is always going to be a terrible time for a family, but having simple...

2014-04-16 00:21:06

TOKYO, April 16, 2014 /PRNewswire/ -- Ajinomoto Pharmaceuticals Co., Ltd. announced on April 16 that the abstract of phase 2a clinical study data of an oral alpha 4 integrin antagonist, development code AJM300, has been accepted for presentation at the Digestive Disease Week 2014 (May 3 - 6 in Chicago, USA). The contents of data will be presented at the beginning of Joint Presidential Plenary Session collaborated by the American Society for Gastrointestinal Endoscopy and the American...

2014-04-15 12:30:30

BOSTON, April 15, 2014 /PRNewswire-USNewswire/ -- Boston City Council Committee on Government Operations, chaired by Councilors Michael Flaherty & Tito Jackson, to conduct April 16 hearing on Docket #0227, An Ordinance Regarding the Prohibition of Research Designated as Biosafety Level 4, Sponsored by Councilors Charles Yancey, Tito Jackson & Ayanna Pressley. http://photos.prnewswire.com/prnvar/20140415/73231 Community residents, scientific experts and civic advocates to...


Latest Bioethics Reference Libraries

OncoMouse
2013-10-02 09:29:43

The OncoMouse or Harvard Mouse is a type of laboratory mouse that has been genetically modified utilizing modification designed by Philip Leder and Timothy A. Stewart, of Harvard University, to carry a certain gene called an activated oncogene. The activated oncogene considerably increases the mouse’s vulnerability to cancer, therefore making the mouse suitable for cancer research. The rights to the invention were owned by DuPont until recently. The USPTO found that the patent expired in...

More Articles (1 articles) »
Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'